Vivos (RDGL) FCF Margin Growth (1y) (2011 - 2025)
Vivos (RDGL) FCF Margin Growth (1y) (2011 - 2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF Margin Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 183.06 Bn | 175.76 Bn | 6.27 Bn | -80.00 |
| 2 | Stryker | 128.66 Bn | 125.78 Bn | 3.81 Bn | 473.00 |
| 3 | Medtronic | 108.82 Bn | 99.60 Bn | 6.41 Bn | -192.00 |
| 4 | Boston Scientific | 68.43 Bn | 66.98 Bn | 3.61 Bn | -431.00 |
| 5 | Edwards Lifesciences | 48.29 Bn | 44.61 Bn | 1.29 Bn | -1,716.00 |
| 6 | GE HealthCare Technologies | 28.37 Bn | 26.08 Bn | 1.98 Bn | -125.00 |
| 7 | Dexcom | 28.29 Bn | 27.18 Bn | 750.30 Mn | 2,833.00 |
| 8 | Smith & Nephew | 26.89 Bn | 26.31 Bn | - | - |
| 9 | Koninklijke Philips | 25.43 Bn | 22.31 Bn | 2.07 Bn | 2,811.00 |
| 10 | Vivos | 26.71 Mn | 25.15 Mn | -3,105.00 | 724,783.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 724,783.00 |
| Sep 30, 2025 | -1.43 Mn |
| Jun 30, 2025 | -139,739.00 |
| Mar 31, 2025 | 610,838.00 |
| Sep 30, 2024 | -695,481.00 |
| Jun 30, 2024 | 220,329.00 |
| Mar 31, 2024 | -291,643.00 |
| Sep 30, 2023 | 118,312.00 |
| Jun 30, 2023 | -320,626.00 |
| Mar 31, 2023 | -193,761.00 |
| Sep 30, 2022 | -315,725.00 |
| Sep 30, 2021 | 143,124.00 |
| Sep 30, 2020 | -31,539.00 |
| Mar 31, 2017 | 726,189.00 |
| Sep 30, 2016 | 7.83 Mn |
| Mar 31, 2016 | -1.19 Mn |
| Mar 31, 2015 | 85,950.00 |
| Mar 31, 2014 | -82,251.00 |
| Sep 30, 2013 | 68,063.00 |
| Mar 31, 2013 | -180,528.00 |